Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.270
+0.005 (0.40%)
At close: Aug 7, 2026, 4:00 PM EDT
1.348
+0.078 (6.13%)
Pre-market: Aug 10, 2026, 7:13 AM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $196.22 million as of August 10, 2026. Its market cap has increased by 84.76% in one year.
Market Cap
196.22M
Enterprise Value
145.09M
1-Year Change
84.76%
Ranking
Category
Stock Price
$1.27
ChartMarket Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $196.22M, a decrease of -51.46%. That is a compound annual growth rate of -5.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 196.20M | 14.34% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 218.64M |
| Conexeu Sciences | 218.62M |
| AN2 Therapeutics | 213.22M |
| Atrium Therapeutics | 212.45M |
| Greenwich LifeSciences | 211.29M |
| Keros Therapeutics | 210.56M |
| Invivyd | 209.85M |
| Immunic | 206.84M |